Daejeon, South Korea

Eun-Young Shim

USPTO Granted Patents = 1 

Average Co-Inventor Count = 27.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eun-Young SHIM: Pioneering Antibody-Drug Conjugates

Introduction

Eun-Young Shim is an accomplished inventor based in Daejeon, South Korea. With a focus on innovative therapeutic approaches, Shim has made significant contributions to the field of biotechnology, particularly in the development of antibody-drug conjugates (ADCs).

Latest Patents

Eun-Young Shim holds a patent for "Antibody-drug conjugates comprising anti-B7-H3 antibodies." This groundbreaking invention involves the conjugation of active agents to the anti-B7-H3 antibody through a specialized linker, which includes a unit that covalently connects these active agents to the antibody. The patent encompasses not only monoclonal antibodies but also various antigen-binding fragments, variants, and bispecific forms that target the B7-H3 protein. The methods outlined in the patent suggest diverse therapeutic, diagnostic, and prophylactic applications, highlighting Shim’s role in advancing cancer treatment strategies.

Career Highlights

Throughout his career, Eun-Young Shim has collaborated with various organizations dedicated to research and innovation. Notably, he has worked with Intocell, Inc. and Y-biologics Inc., where he applied his expertise in biotechnology to enhance drug development processes. His extensive work in these companies underscores his commitment to tackling complex medical challenges through innovative solutions.

Collaborations

Eun-Young Shim has collaborated with talented individuals in his field, including Taekyo Park and Sunyoung Kim. These partnerships have facilitated the exchange of ideas and expertise, contributing to the development of cutting-edge technologies in antibody-drug conjugates and related therapeutic areas.

Conclusion

Eun-Young Shim’s work exemplifies the innovative spirit in the realm of biotechnology. With his patent on antibody-drug conjugates, he is paving the way for new therapeutic options against cancer and other diseases. His collaborations and career endeavors reflect a dedication to improving healthcare through the power of invention and scientific discovery.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…